Literature DB >> 18513727

Atherogenic diet leads to posttranslational down-regulation of murine hepatocyte SR-BI expression.

Andreas Niemeier1, Werner J Kovacs, Wolfgang Strobl, Herbert Stangl.   

Abstract

The scavenger receptor class B, type I (SR-BI) mediates selective cholesteryl ester uptake by the liver and thereby exerts a systemic anti-atherogenic effect. It is unknown, however, whether exogenous cholesterol contributes to the regulation of hepatic SR-BI expression. Atherosclerosis resistant SJL and susceptible C57Bl/6 mice were challenged with atherogenic diets that lead to an increase of both plasma and liver cholesterol. The increase of cholesterol was accompanied by a marked posttranslational down-regulation of liver SR-BI expression. On average, we observed a threefold decrease of SR-BI protein while mRNA levels were slightly increased in both strains. Mice with transgenic over-expression of the sterol regulatory element binding proteins (SREBPs) were used as a model that displays endogenously increased liver cholesterol concentrations. In SREBP-1a and -1c transgenic mice on normal chow, SR-BI was transcriptionally down-regulated. When fed the atherogenic diet, the posttranslational SR-BI regulation was still functional on this background. Down-regulation of SR-BI did not alter the hepatocyte surface expression pattern, but was accompanied by a decrease of PDZK1, an adaptor protein recently identified to control SR-BI protein expression levels in the liver and intestine. Taken together, a diet-induced increase of plasma and hepatic cholesterol levels leads to a posttranscriptional down-regulation of SR-BI in mouse liver via a mechanism likely involving PDZK1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18513727     DOI: 10.1016/j.atherosclerosis.2008.04.018

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  The thyromimetic T-0681 protects from atherosclerosis.

Authors:  Ivan Tancevski; Andreas Wehinger; Egon Demetz; Julia Hoefer; Philipp Eller; Eva Huber; Ursula Stanzl; Kristina Duwensee; Kristina Auer; Wilfried Schgoer; Volker Kuhn; Catherine Fievet; Frans Stellaard; Mats Rudling; Bernhard Foeger; Josef R Patsch; Andreas Ritsch
Journal:  J Lipid Res       Date:  2008-12-22       Impact factor: 5.922

2.  Ras/mitogen-activated protein kinase (MAPK) signaling modulates protein stability and cell surface expression of scavenger receptor SR-BI.

Authors:  Peta Wood; Vishwaroop Mulay; Masoud Darabi; Karen Cecilia Chan; Joerg Heeren; Albert Pol; Gilles Lambert; Kerry-Anne Rye; Carlos Enrich; Thomas Grewal
Journal:  J Biol Chem       Date:  2011-04-27       Impact factor: 5.157

Review 3.  Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI.

Authors:  Olivier Kocher; Monty Krieger
Journal:  Curr Opin Lipidol       Date:  2009-06       Impact factor: 4.776

4.  PDZK1 prevents neointima formation via suppression of breakpoint cluster region kinase in vascular smooth muscle.

Authors:  Wan Ru Lee; Anastasia Sacharidou; Erica Behling-Kelly; Sarah C Oltmann; Weifei Zhu; Mohamed Ahmed; Robert D Gerard; David Y Hui; Jun-ichi Abe; Philip W Shaul; Chieko Mineo
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

5.  Scavenger receptor B1, the HDL receptor, is expressed abundantly in liver sinusoidal endothelial cells.

Authors:  Latha P Ganesan; Jessica M Mates; Alana M Cheplowitz; Christina L Avila; Jason M Zimmerer; Zhili Yao; Andrei Maiseyeu; Murugesan V S Rajaram; John M Robinson; Clark L Anderson
Journal:  Sci Rep       Date:  2016-02-11       Impact factor: 4.379

Review 6.  Scavenger receptor class B member 1 protein: hepatic regulation and its effects on lipids, reverse cholesterol transport, and atherosclerosis.

Authors:  Anthony P Kent; Ioannis M Stylianou
Journal:  Hepat Med       Date:  2011-04-08

7.  Differential basolateral-apical distribution of scavenger receptor, class B, type I in cultured cells and the liver.

Authors:  Stefanie Fruhwürth; Werner J Kovacs; Robert Bittman; Simon Messner; Clemens Röhrl; Herbert Stangl
Journal:  Histochem Cell Biol       Date:  2014-07-25       Impact factor: 4.304

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.